Trial Profile
Switching from natalizumab to fingolimod in patients with relapsing-remitting multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Methylprednisolone
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 19 Dec 2015 New trial record